Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
Quick Stats
Jan 30, 202651.7
AI Score
HOLD2.01
Volume Ratio
Apr 01, 2026
Next Earnings
9
+ve Days (30d)
21
-ve Days (30d)
ATOS Stock Summary
Last updated Jan 30, 2026
ATOS is currently trading at $0.565, positioned below its 200-day moving average of $0.81, suggesting bearish momentum. The stock has a 52-week range of $0.5321 to $1.29.
Technical Analysis: The 50-day moving average stands at $0.7, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.07, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.055, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ATOS at 51.7/100 with a HOLD recommendation.
ATOS (Atossa Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.07 |
| CMF (20) | -0.055 |
| ROC (10) | -2.603 |
| ADX (14) | 15.577 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.024 |
| AROONOSC (14) | -21.429 |
| WILLAMS %R (14) | -83.375 |
| MFI (14) | 54.785 |
ATOS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ATOS Price vs Max Options Open Interest
ATOS Max Change In Options Open Interest
ATOS Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ATOS Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ATOS Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ATOS Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Atossa Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ATOS Moving Averages Analysis
ATOS (Atossa Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.63 |
| 20 | 0.63 |
| 30 | 0.65 |
| 50 | 0.7 |
| 100 | 0.8 |
| 200 | 0.81 |
ATOS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 79.6 million |
| Earnings/Share ($) | -0.23 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.25 |
| EPS Estimate Next Year ($) | -0.2867 |
| WallStreet Target Price ($) | 5.75 |
| Most Recent Quarter |